ZA974806B - Prostaglandin synthase-2 inhibitor. - Google Patents

Prostaglandin synthase-2 inhibitor.

Info

Publication number
ZA974806B
ZA974806B ZA9704806A ZA974806A ZA974806B ZA 974806 B ZA974806 B ZA 974806B ZA 9704806 A ZA9704806 A ZA 9704806A ZA 974806 A ZA974806 A ZA 974806A ZA 974806 B ZA974806 B ZA 974806B
Authority
ZA
South Africa
Prior art keywords
inhibitor
prostaglandin synthase
prostaglandin
synthase
Prior art date
Application number
ZA9704806A
Inventor
Jr Joseph F Dellaria
Todd H Gane
Keith W Woods
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA974806B publication Critical patent/ZA974806B/en

Links

ZA9704806A 1996-06-21 1997-05-30 Prostaglandin synthase-2 inhibitor. ZA974806B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66778196A 1996-06-21 1996-06-21

Publications (1)

Publication Number Publication Date
ZA974806B true ZA974806B (en) 1997-12-30

Family

ID=27663520

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704806A ZA974806B (en) 1996-06-21 1997-05-30 Prostaglandin synthase-2 inhibitor.

Country Status (1)

Country Link
ZA (1) ZA974806B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Similar Documents

Publication Publication Date Title
AU4073997A (en) 1,4-heterocyclic metallprotease inhibitors
ZA977693B (en) 1,3-diheterocyclic metalloprotease inhibitors.
ZA977086B (en) NAALADase inhibitors.
ZA989230B (en) Prostaglandin agonists.
ZA9710956B (en) New Ó-aminoacetophenone photoinitiators.
ZA997794B (en) Prostaglandin product.
ZA9711092B (en) Novel compounds.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA9610858B (en) Heteroclyclic compounds.
ZA979199B (en) Aminothiophenecarboxamides.
ZA99680B (en) Ester compounds.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA972514B (en) Pro-fragrance compound.
AU3944497A (en) 1,2-diarylindole as cox-2 inhibitors
ZA977810B (en) Brake beam.
ZA9711567B (en) Compounds.
ZA976056B (en) Block former.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA975861B (en) Bromotiacumicin compounds.
TR199700994A3 (en) Sync scheme.
ZA972061B (en) New method.
ZA979725B (en) Benzoaxozole derivative.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA964560B (en) Anit-viral compounds.
ZA972944B (en) Novel retinoids.